COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.

ABSTRACT: Vaccine manufacturers from developing countries have a proven track record of developing, producing, and supplying high-quality vaccines globally. However, due to the complexity of vaccine manufacturing, numerous stakeholder organizations support manufacturers across a variety of functions. To optimize the support from stakeholders it is instrumental to first understand which manufacturing processes these manufacturers require support for and what support functions are most beneficial. To this end, the Developing Countries Vaccine Manufacturers Network designed a comprehensive survey to assess the specific needs of the Network's member organizations. We found that almost all sampled manufacturers are interested in obtaining funding or technology transfers for COVID-19 vaccines. Furthermore

SUBMITTER: Hayman B 

PROVIDER: S-EPMC8275514 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature